JP2024502740A5 - - Google Patents

Info

Publication number
JP2024502740A5
JP2024502740A5 JP2023537184A JP2023537184A JP2024502740A5 JP 2024502740 A5 JP2024502740 A5 JP 2024502740A5 JP 2023537184 A JP2023537184 A JP 2023537184A JP 2023537184 A JP2023537184 A JP 2023537184A JP 2024502740 A5 JP2024502740 A5 JP 2024502740A5
Authority
JP
Japan
Application number
JP2023537184A
Other languages
Japanese (ja)
Other versions
JPWO2022133148A5 (https=
JP2024502740A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/063920 external-priority patent/WO2022133148A1/en
Publication of JP2024502740A publication Critical patent/JP2024502740A/ja
Publication of JPWO2022133148A5 publication Critical patent/JPWO2022133148A5/ja
Publication of JP2024502740A5 publication Critical patent/JP2024502740A5/ja
Pending legal-status Critical Current

Links

JP2023537184A 2020-12-17 2021-12-16 長時間作用型グルカゴン様ポリペプチド-1(glp-1)受容体アゴニスト及び使用方法 Pending JP2024502740A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063126736P 2020-12-17 2020-12-17
US63/126,736 2020-12-17
PCT/US2021/063920 WO2022133148A1 (en) 2020-12-17 2021-12-16 Long acting glucagon like polypeptide-1 (glp-1) receptor agonists and methods of use

Publications (3)

Publication Number Publication Date
JP2024502740A JP2024502740A (ja) 2024-01-23
JPWO2022133148A5 JPWO2022133148A5 (https=) 2024-12-23
JP2024502740A5 true JP2024502740A5 (https=) 2024-12-23

Family

ID=80123475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023537184A Pending JP2024502740A (ja) 2020-12-17 2021-12-16 長時間作用型グルカゴン様ポリペプチド-1(glp-1)受容体アゴニスト及び使用方法

Country Status (12)

Country Link
US (2) US12084485B2 (https=)
EP (1) EP4263587A1 (https=)
JP (1) JP2024502740A (https=)
KR (1) KR20230156689A (https=)
CN (1) CN116917311A (https=)
AR (1) AR124395A1 (https=)
AU (1) AU2021400738A1 (https=)
CA (1) CA3202389A1 (https=)
IL (1) IL303686A (https=)
MX (1) MX2023007224A (https=)
TW (1) TW202237628A (https=)
WO (1) WO2022133148A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022159395A1 (en) 2021-01-20 2022-07-28 Viking Therapeutics, Inc. Compositions and methods for the treatment of metabolic and liver disorders
MX2024003236A (es) 2021-09-15 2024-06-19 Viking Therapeutics Inc Composiciones y metodos para el tratamiento de trastornos metabolicos y hepaticos.
AU2024218747A1 (en) * 2023-02-10 2025-08-28 Hangzhou Sciwind Biosciences Co., Ltd. Polypeptide and derivative thereof, composition, and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100256056A1 (en) 2007-09-07 2010-10-07 Zheng Xin Dong Analogues of exendin-4 and exendin-3
SMT201700583T1 (it) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
JP6165168B2 (ja) * 2011-12-22 2017-07-19 ファイザー・インク 抗糖尿病化合物
UA116217C2 (uk) * 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
RU2760007C2 (ru) * 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
AU2017277594A1 (en) * 2016-06-09 2019-02-07 Medimmune Limited Protease-resistant mono-lipidated peptides
CN111333714A (zh) 2020-03-05 2020-06-26 成都奥达生物科技有限公司 一种长效glp-1化合物

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2024502740A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)